The role of NFAT in the pathogenesis and targeted therapy of hematological malignancies

The nuclear factor of activated T cells (NFAT) family is well known for the survival of hemopoietic cells and plays an important role in the immune response. In recent decades, NFAT alteration was discovered in hematological malignancies, suggesting that targeted NFAT therapy may be a promising strategy for the treatment of hematological malignancies. In this review, we present an overview of the NFAT signaling pathway in lymphocytes as well as aberrant NFAT in hematological malignancies. Moreover, therapeutically targeting NFAT in hematological malignancies is also discussed in this review.

Automated summary

The NFAT family plays a crucial role in immune response and has been found to be altered in hematological malignancies. Therapeutically targeting NFAT in the treatment of these malignancies could be a promising strategy.